Internal Medicine, Gastroenterology · Bayamon, PR
NPI
1144262270
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
Bayamon Medical Plz, Suite 708 Carretera #2
Bayamon, PR, 00959
Phone (787) 200-1121
Medicare paid, 2024
$11K
107 services
Medicare patients, 2024
39
Average age 75
Drug cost, 2024
$570K
6,580 prescriptions
Company payments, 2025
$379
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rafael Solis-Mounier was code 99213 (office e&m - established), 47 times for 30 patients. In total Rafael Solis-Mounier billed 107 services in 7 codes, and Medicare paid $11K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 47 | 30 | $64.30 | $3,022 |
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Office | 22 | 18 | $44.19 | $972 |
| 99203 Office E&M - New | Office | 14 | 14 | $68.72 | $962 |
By year: 2022 $19K for 162 services; 2023 $14K for 126 services; 2024 $11K for 107 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rafael Solis-Mounier prescribed most often to Medicare patients was Omeprazole, with 1,450 prescriptions and refills. In total Rafael Solis-Mounier wrote 6,580 Medicare prescriptions that cost $570K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 1,450 | 1,659 | 528 | $9,812 |
| Famotidine Generic | 1,208 | 1,375 | 389 | $9,220 |
| Pantoprazole Sodium Generic | 535 | 611 | 184 | $4,350 |
| Glycopyrrolate Generic | 395 | 395 | 176 | $5,073 |
| Suprep Sodium, Potassium,mag Sulfates | 346 | 346 | 341 | $41K |
| Midazolam Hcl Midazolam Hcl/Pf | 332 | 332 | 315 | $911 |
| Dicyclomine Hcl Generic | 271 | 271 | 160 | $2,674 |
| Midazolam Hcl Generic | 253 | 253 | 243 | $674 |
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 240 | 240 | 239 | $40K |
| Fentanyl Citrate Fentanyl Citrate/Pf | 192 | 192 | 183 | $637 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 129 | 129 | 128 | $10K |
| Sucralfate Generic | 121 | 125 | 46 | $7,888 |
| Linzess Linaclotide | 95 | 99 | 28 | $54K |
| Cholestyramine Cholestyramine (With Sugar) | 86 | 97 | 43 | $6,066 |
| Amitriptyline Hcl Generic | 77 | 77 | 20 | $429 |
Brand drugs: - claims; generic drugs: 5,434 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rafael Solis-Mounier $379 ($379 in general payments such as food, travel and fees) from 5 companies. The largest payer was Abbvie Inc. with $258.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.